Case Studies2020-11-19T22:10:23-08:00

Case Studies

MariMed Reports Q2 2025 Financial Results

NORWOOD – MariMed Inc. released its financial results for Q2 2025 ended June 30, reflecting a blend of operational growth and financial challenges. The company reported revenue of $39.6 million, a slight decline from $40.4 ...

  • Verano Holdings Corp.

Verano Holdings Corp Reports Q2 2025 Financial Results

CHICAGO – Verano Holdings Corp., a multi-state Cannabis operator, released its financial results for the second quarter of 2025, reflecting a period of operational streamlining amid market challenges. The consolidated financial statements, prepared under U.S. ...

Jushi Holdings Reports Q2 2025 Financial Results

LOS ANGELES – Jushi Holdings Inc. reported its Q2 2025 financial results, reflecting modest revenue growth and operational advances as it expands its retail footprint and refines its cultivation strategy. The company posted revenue of ...

MariMed Reports Q2 2025 Financial Results

NORWOOD – MariMed Inc. released its financial results for Q2 2025 ended June 30, reflecting a blend of operational growth and financial challenges. The company reported revenue of $39.6 million, a slight decline from $40.4 ...

  • Verano Holdings Corp.

Verano Holdings Corp Reports Q2 2025 Financial Results

CHICAGO – Verano Holdings Corp., a multi-state Cannabis operator, released its financial results for the second quarter of 2025, reflecting a period of operational streamlining amid market challenges. The consolidated financial statements, prepared under U.S. ...

High-Paying Roles in the Cannabis Industry

LOS ANGELES- As the cannabis industry continues its expansion across the United States, it presents a variety of high-paying career opportunities. Positions such as cultivation directors, compliance officers, and extraction technicians are in demand, offering ...

  • Fast Buds - German cannabis legalisation

German Medical Cannabis Market Sees Significant Growth

LOS ANGELES- Germany's medical cannabis industry is experiencing substantial growth, driven by recent regulatory reforms and increasing patient demand. Companies such as Cantourage are at the forefront of this expansion, capitalizing on the evolving legal ...

Silo Pharma Initiates Safety Study for PTSD Drug SPC-15

LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, has commenced a 7-day safety and toxicology study for its lead candidate, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD). The study is being conducted ...

  • Village Farms International

Village Farms International Reports Q1 2025

LOS ANGELES- Village Farms International Inc. has announced its financial results for the first quarter of 2025, highlighting a strategic pivot towards its cannabis operations and the privatization of certain fresh produce assets. For the ...

Cybin Secures Additional U.S. Patent for CYB003

LOS ANGELES- Cybin Inc. a biopharmaceutical company, announced the granting of U.S. patent 12,291,499 by the United States Patent and Trademark Office. This patent pertains to pharmaceutical compositions and oral dosage forms within the company's ...

Cronos Group Reports First Quarter 2025

LOS ANGELES- Cronos Group Inc. reported its financial results for the first quarter ended March 31, 2025, indicating a net revenue of $32.3 million, a 28% increase compared to the same period in 2024. The ...

THC Design Repositions for National Expansion

LOS ANGELES- THC Design, a California-based cannabis company, has undertaken a comprehensive rebranding initiative in collaboration with New York creative studio Super Okay. The effort aims to transition the company from a regional entity to ...

Maine Considers Stricter Medical Cannabis Regulations

LOS ANGELES- Maine lawmakers are evaluating two legislative proposals aimed at enhancing safety standards within the state's medical cannabis program. The bills, LD 104 and LD 1847, seek to introduce mandatory testing for contaminants and ...

Organigram to Announce Q2 Fiscal 2025 Results

LOS ANGELES- Organigram Global Inc. is scheduled to release its financial results for the second quarter of fiscal 2025, ending March 31, on Monday, May 12, 2025, before market open. The company will host a ...

Subscribe To Our Newsletter

Go to Top